ID

21439

Beschreibung

Acute Promyelocytic Leukemia 2006 (APL); ODM derived from: https://clinicaltrials.gov/show/NCT00378365

Link

https://clinicaltrials.gov/show/NCT00378365

Stichworte

Versionen (2)
  1. 21.04.17 21.04.17 -
  2. 21.04.17 21.04.17 -
Hochgeladen am

21. April 2017

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Leukemia, Promyelocytic, Acute NCT00378365

Englisch

Eligibility Leukemia, Promyelocytic, Acute NCT00378365

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
diagnosis of apl based on morphological grounds, which will have to be confirmed by the presence of t(15;17) and/or pml-rara rearrangement with characterization of the bcr subtype (pml-rar characterization).
Beschreibung

Acute Promyelocytic Leukemia | t(15;17)(q22;q12) | t(15;17)(PML,RARA) | PML-RARa bcr1 fusion protein, human

Datentyp

boolean

Alias
UMLS CUI [1]
C0023487
UMLS CUI [2]
C1515724
UMLS CUI [3]
C1979990
UMLS CUI [4]
C3493223
untreated patients.
Beschreibung

Patients Untreated

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C0332155
no contraindication to intensive chemotherapy (especially well documented cardiac contraindication to idarubicin).
Beschreibung

Chemotherapy intense Medical contraindication Absent | Idarubicin Medical contraindication cardiac Absent

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C0522510
UMLS CUI [1,3]
C1301624
UMLS CUI [1,4]
C0332197
UMLS CUI [2,1]
C0020789
UMLS CUI [2,2]
C1301624
UMLS CUI [2,3]
C0018787
UMLS CUI [2,4]
C0332197
in female patients: absence of pregnancy and adequate contraceptive methods (due to teratogenetic effects of atra in early pregnancy).
Beschreibung

Gender Contraceptive methods | Pregnancy Absent | Tretinoin | Teratogenic effects Pregnancy Early

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0079399
UMLS CUI [1,2]
C0700589
UMLS CUI [2,1]
C0032961
UMLS CUI [2,2]
C0332197
UMLS CUI [3]
C0040845
UMLS CUI [4,1]
C0232910
UMLS CUI [4,2]
C0032961
UMLS CUI [4,3]
C1279919
absence of hypersensitivity to arsenic derivatives.
Beschreibung

Arsenic derivatives Hypersensitivity Absent

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0003818
UMLS CUI [1,2]
C0243072
UMLS CUI [1,3]
C0020517
UMLS CUI [1,4]
C0332197
no qt interval prolongation or complete atria-ventricular block.
Beschreibung

Prolonged QT interval Absent | Complete atrioventricular block Absent

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0151878
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C0151517
UMLS CUI [2,2]
C0332197
written informed consent.
Beschreibung

Informed Consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients already treated.
Beschreibung

Patients Treated

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C1522326
patients with contraindication to intensive chemotherapy, especially well documented cardiac contraindication to idarubicin.
Beschreibung

Medical contraindication Chemotherapy intense | Medical contraindication cardiac Idarubicin

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C0392920
UMLS CUI [1,3]
C0522510
UMLS CUI [2,1]
C1301624
UMLS CUI [2,2]
C0018787
UMLS CUI [2,3]
C0020789
in female patients: pregnancy or absence of adequate contraceptive methods
Beschreibung

Pregnancy | Gender Contraceptive methods Absent

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2,1]
C0079399
UMLS CUI [2,2]
C0700589
UMLS CUI [2,3]
C0332197
qt interval prolongation or complete atria-ventricular block.
Beschreibung

Prolonged QT interval | Complete atrioventricular block

Datentyp

boolean

Alias
UMLS CUI [1]
C0151878
UMLS CUI [2]
C0151517
hypersensitivity to arsenic derivatives.
Beschreibung

Hypersensitivity Arsenic derivatives

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0003818
UMLS CUI [1,3]
C0243072
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Leukemia, Promyelocytic, Acute NCT00378365

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Acute Promyelocytic Leukemia | t(15;17)(q22;q12) | t(15;17)(PML,RARA) | PML-RARa bcr1 fusion protein, human
Item
diagnosis of apl based on morphological grounds, which will have to be confirmed by the presence of t(15;17) and/or pml-rara rearrangement with characterization of the bcr subtype (pml-rar characterization).
boolean
C0023487 (UMLS CUI [1])
C1515724 (UMLS CUI [2])
C1979990 (UMLS CUI [3])
C3493223 (UMLS CUI [4])
Patients Untreated
Item
untreated patients.
boolean
C0030705 (UMLS CUI [1,1])
C0332155 (UMLS CUI [1,2])
Chemotherapy intense Medical contraindication Absent | Idarubicin Medical contraindication cardiac Absent
Item
no contraindication to intensive chemotherapy (especially well documented cardiac contraindication to idarubicin).
boolean
C0392920 (UMLS CUI [1,1])
C0522510 (UMLS CUI [1,2])
C1301624 (UMLS CUI [1,3])
C0332197 (UMLS CUI [1,4])
C0020789 (UMLS CUI [2,1])
C1301624 (UMLS CUI [2,2])
C0018787 (UMLS CUI [2,3])
C0332197 (UMLS CUI [2,4])
Gender Contraceptive methods | Pregnancy Absent | Tretinoin | Teratogenic effects Pregnancy Early
Item
in female patients: absence of pregnancy and adequate contraceptive methods (due to teratogenetic effects of atra in early pregnancy).
boolean
C0079399 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C0032961 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0040845 (UMLS CUI [3])
C0232910 (UMLS CUI [4,1])
C0032961 (UMLS CUI [4,2])
C1279919 (UMLS CUI [4,3])
Arsenic derivatives Hypersensitivity Absent
Item
absence of hypersensitivity to arsenic derivatives.
boolean
C0003818 (UMLS CUI [1,1])
C0243072 (UMLS CUI [1,2])
C0020517 (UMLS CUI [1,3])
C0332197 (UMLS CUI [1,4])
Prolonged QT interval Absent | Complete atrioventricular block Absent
Item
no qt interval prolongation or complete atria-ventricular block.
boolean
C0151878 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0151517 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Informed Consent
Item
written informed consent.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Patients Treated
Item
patients already treated.
boolean
C0030705 (UMLS CUI [1,1])
C1522326 (UMLS CUI [1,2])
Medical contraindication Chemotherapy intense | Medical contraindication cardiac Idarubicin
Item
patients with contraindication to intensive chemotherapy, especially well documented cardiac contraindication to idarubicin.
boolean
C1301624 (UMLS CUI [1,1])
C0392920 (UMLS CUI [1,2])
C0522510 (UMLS CUI [1,3])
C1301624 (UMLS CUI [2,1])
C0018787 (UMLS CUI [2,2])
C0020789 (UMLS CUI [2,3])
Pregnancy | Gender Contraceptive methods Absent
Item
in female patients: pregnancy or absence of adequate contraceptive methods
boolean
C0032961 (UMLS CUI [1])
C0079399 (UMLS CUI [2,1])
C0700589 (UMLS CUI [2,2])
C0332197 (UMLS CUI [2,3])
Prolonged QT interval | Complete atrioventricular block
Item
qt interval prolongation or complete atria-ventricular block.
boolean
C0151878 (UMLS CUI [1])
C0151517 (UMLS CUI [2])
Hypersensitivity Arsenic derivatives
Item
hypersensitivity to arsenic derivatives.
boolean
C0020517 (UMLS CUI [1,1])
C0003818 (UMLS CUI [1,2])
C0243072 (UMLS CUI [1,3])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video